聚醇抑制纤维的形成:分子机制,挑战和潜在的解决方案
Shilpa Sharma1, Shashank Deep2
1Department of Chemistry and Biochemistry, University of Wisconsin, Milwaukee, Wisconsin, USA.
Chemical communications (Cambridge, England)
|June 5, 2024
概括
来自植物的多可以抑制和分解与神经退行性疾病相关的有害蛋白纤维. 纳米技术可以通过提高溶解度和生物可用性来增强它们的治疗潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 纤维细胞的形成是神经退行性疾病的核心,如阿尔茨海默氏症和帕金森症.
- 植物衍生化合物聚醇在预防和治疗粉样化症方面表现出潜在的潜力.
- 了解多与氨基原蛋白的相互作用是治疗开发的关键.
研究的目的:
- 探索聚醇抑制纤维细胞形成的分子机制.
- 研究多如何与氨基原蛋白相互作用并破坏纤维组合.
- 突出克服多生物可用性和疗效方面的挑战的战略.
主要方法:
- 审查现有关于多 - 蛋白相互作用的研究.
- 对结构生物学,计算建模和生物物理数据的分析.
- 检查基于纳米技术的方法来提供多.
主要成果:
- 聚醇表现出多种机制,抑制纤维的形成,破坏预制纤维,或改变纤维的形态.
- 多的疗效取决于特定的多和蛋白质标.
- 纳米技术战略在增强多溶解性和生物可用性方面显示出前景.
结论:
- 聚醇代表了神经退行性疾病和粉样化症的有前途的治疗策略.
- 在临床应用中,克服多提供挑战至关重要.
- 在结构生物学和计算建模领域的持续研究将推动基于多的疗法.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:16Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
519
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
519